The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the severity of side effects they experience.
A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for their effectiveness in reducing body weight.
The key question before us is simple: Whose interest should guide food policy in India? The credibility of India's food regulatory system depends on the answer to this question.
With semaglutide patent ending, Indian pharma firms are set to launch lower-cost versions, prompting hospitals and clinics to expand obesity services ahead of a surge in demand.
Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.
Children with certain genetic defects affecting hunger control can become severely obese from the age of one or two. Findings suggest that medicines based on GLP-1 hormone may work.
The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World Health Organisation and Columbia University.
Study analysed data from over 540,000 adults in Finland and the UK. To study worldwide estimates, the researchers then used global data from the Global Burden of Diseases (GBD) Study.
Since the bulk of citizens did not regard drinking as a crime, they had no respect for the prohibition laws and did not cooperate with the police, wrote MV Venkata Rao in 1962.
We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.
COMMENTS